<HashMap><database>biostudies-arrayexpress</database><scores/><additional><omics_type>Unknown</omics_type><omics_type>Transcriptomics</omics_type><omics_type>Genomics</omics_type><omics_type>Proteomics</omics_type><submitter>Andrej Besse</submitter><instrument_platform>MGISEQ-2000RS</instrument_platform><study_type>RNA-seq of coding RNA</study_type><organism>Homo sapiens</organism><species>Homo sapiens</species><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/E-MTAB-15466</full_dataset_link><description>AMO-1 cell line after 8h of Ceritinib, Carfilzomib treatment and their combination. Cells were continuously treated for 8 h with 4uM Ceritinib and 5nM Carfilzomib. Cell pelets were stored at -80 degree and send on dry ice to BGI company.</description><repository>biostudies-arrayexpress</repository><sample_protocol>Growth Protocol - Cells were grown in RPMI medium supplemented with 10% FBS and anitbiotics</sample_protocol><sample_protocol>Sample Treatment - Cells were treated with Carfilzomib 5nM or Ceritinib 4uM or combination or without for 8h</sample_protocol><sample_protocol>Sample Collection - Cell were harvested form T75 flask and washed 2x with PBS and snap frozen in Liquid nitrogen</sample_protocol><sample_protocol>Library Construction - polyadenylated RNA was enriched using oligo(dT) magnetic beads. First- and second-strand cDNA synthesis was performed using reverse transcriptase and random hexamer primers. After end repair, A-tailing, and adaptor ligation, libraries were amplified by PCR. The final libraries were quality-checked using Qubit and Bioanalyzer before sequencing. Library construction followed BGI’s standard mRNA-seq protocol</sample_protocol><sample_protocol>Sequencing - Sequencing was performed by BGI using the DNBseq platform, generating paired-end 150 bp reads (PE150). Libraries were circularized, amplified via rolling circle replication to form DNA nanoballs (DNBs), and loaded onto patterned arrays for high-throughput sequencing</sample_protocol><sample_protocol>Nucleic Acid Extraction - Total RNA was extracted by BGI from the submitted tissue samples using TRIzol reagent or a similar phenol-based method, following their standard RNA extraction workflow. RNA integrity and quantity were assessed using Bioanalyzer or similar QC platforms</sample_protocol><figure_sub>Organization</figure_sub><figure_sub>MINSEQE Score</figure_sub><figure_sub>Assays and Data</figure_sub><figure_sub>MAGE-TAB Files</figure_sub><pubmed_authors>Andrej Besse</pubmed_authors></additional><is_claimable>false</is_claimable><name>AMO-1 cell line after 8h of Ceritinib, Carfilzomib treatment and their combination</name><description>AMO-1 cell line after 8h of Ceritinib, Carfilzomib treatment and their combination. Cells were continuously treated for 8 h with 4uM Ceritinib and 5nM Carfilzomib. Cell pelets were stored at -80 degree and send on dry ice to BGI company.</description><dates><release>2025-12-15T00:00:00Z</release><modification>2025-12-15T02:01:04.983Z</modification><creation>2025-08-08T15:19:06.566Z</creation></dates><accession>E-MTAB-15466</accession><cross_references><ENA>ERP178570</ENA><Biostudies>E-MTAB-15465</Biostudies><EFO>EFO_0002944</EFO><EFO>EFO_0004170</EFO><EFO>EFO_0003789</EFO><EFO>EFO_0005518</EFO><EFO>EFO_0003738</EFO><EFO>EFO_0004184</EFO><EFO>EFO_0003969</EFO></cross_references></HashMap>